Learn more about our China work.
WASHINGTON – New clinical evidence produced in recent weeks has shown the benefits of non-invasive ventilators for use in less severe cases of COVID-19-related respiratory problems, which constitute the majority…
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed® member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…
The objective of this study is to assess the potential impact of pricing regulation of medical devices in Brazil, China, Colombia and India.
Accelerating the advancement of AI could help China tackle some of its most difficult healthcare challenges.